AC
ADAP

Ascend Capital’s Adaptimmune Therapeutics ADAP Stock Holding History

Ascend Capital’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,000
Closed -$353K – 135
2016
Q3 		$353K Sell
50,000
-164,794
-77% -$1.16M 0.02% 114
2016
Q2 		$1.75M Buy
214,794
+164,794
+330% +$1.34M 0.11% 122
2016
Q1 		$406K Buy
+50,000
New +$406K 0.04% 91